This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Aron Tendler, MD, C.BSM
Chief Medical Officer
Dr. Tendler brings years of experience in the treatment of mental disorders as a psychiatrist.
He graduated in 2002 from State University of New York Downstate Medical School in Brooklyn with a distinction in research.
From 2002-2004, he trained at Tulane University in Internal Medicine and Psychiatry followed by two years at the University of Chicago in General Psychiatry, where he was chief resident of the consultation liaison service and course director for psychosomatic medicine.
Dr. Tendler is Board Certified in General Psychiatry, Sleep Medicine and Behavioral Sleep Medicine.
In 2006, Dr. Tendler established Advanced Mental Health Care Inc. in Palm Beach County, Florida, which has since served over 4000 patients.
Dr. Tendler began using TMS clinically in 2009 for a variety of psychiatric and neurological conditions, and his clinical research sites participated in the clinical trial that led to BrainsWay’s FDA clearance.
Currently, he has three clinical research sites studying the efficacy of Deep TMS for bipolar depression, smoking cessation, PTSD and OCD.